Wird geladen...

Sense and nonsense in sensors

Continuous subcutaneous glucose monitoring (CGM) is a developing technology in the treatment of diabetes mellitus. The first randomised controlled trials on its efficacy have been performed. In several studies, CGM lowered HbA(1c) in adult patients with suboptimally controlled type 1 diabetes mellit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hermanides, J., DeVries, J. H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer-Verlag 2010
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2830625/
https://ncbi.nlm.nih.gov/pubmed/20225392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-009-1649-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!